Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

VRP.L (VRP) Regulatory News

Date Source Headline
4th Jan 2013 2:59 pm PRN Statement Regarding Share Price Movement
12th Nov 2012 11:38 am PRN Notice of Interest
15th Oct 2012 2:01 pm PRN Director Shareholding
12th Oct 2012 9:00 am PRN RPL554 Phase I/IIa data presented at ISAF 2012
26th Sep 2012 9:00 am PRN Investor Presentation
17th Sep 2012 10:44 am PRN New Option Scheme and Grant of Options
14th Sep 2012 7:00 am PRN Half-yearly Report
6th Sep 2012 7:00 am PRN Notice of Interim Results
4th Sep 2012 7:30 am PRN Verona Pharma: RPL554 COPD Data Presented at ERS
3rd Sep 2012 9:30 am PRN Notice of Interest
28th Aug 2012 7:00 am PRN US Patent Granted for Verona Pharma's RPL554
9th Jul 2012 7:00 am PRN Verona Pharma Investigates Anti-inflammatory - RPL554
1st Jun 2012 6:14 pm PRN Result of AGM
1st Jun 2012 11:30 am PRN CEO's Statement to Annual General Meeting
8th May 2012 4:56 pm PRN Posting of Annual Report
1st May 2012 7:00 am PRN Verona Pharma appoints new CEO
5th Apr 2012 7:00 am PRN Verona Pharma - Preliminary Unaudited Results
9th Mar 2012 7:00 am PRN Verona Pharma â€" First UK RPL554 anti-inflammatory trial
31st Jan 2012 7:00 am PRN Total Voting Rights
16th Jan 2012 12:19 pm PRN Notification of Major Interest in Shares
5th Jan 2012 10:42 am PRN Result of General Meeting
8th Dec 2011 2:05 pm PRN Completion of GBP3.25 million placing
25th Nov 2011 3:55 pm PRN Holding(s) in Verona Pharma
10th Nov 2011 7:00 am PRN Positive results for COPD pilot study
3rd Nov 2011 7:00 am PRN WH Ireland Limited appointed as Nomad and Broker
20th Sep 2011 7:00 am PRN Issue of Options
7th Sep 2011 7:01 am PRN Interim Report for the six months ended 30 June 2011
7th Sep 2011 7:00 am PRN VRP700 demonstrates significant anti-tussive effects
17th Aug 2011 7:22 am PRN Bronchodilation in asthmatics maintained with RPL554
7th Jun 2011 4:21 pm PRN Director Options
3rd Jun 2011 3:43 pm PRN Result of AGM
3rd Jun 2011 11:09 am PRN AGM Statement
12th May 2011 7:00 am PRN Start of New Phase II Clinical Trial of RPL554
9th May 2011 5:29 pm PRN Correction of AGM date
9th May 2011 4:13 pm PRN Notice of AGM and Issue of Annual Report
21st Apr 2011 7:00 am PRN Appointment of Joint Broker
12th Apr 2011 7:00 am PRN First COPD Trial with RPL554 Begins in Rome
23rd Mar 2011 7:00 am PRN Preliminary Unaudited Results
1st Mar 2011 10:24 am PRN Total Voting Rights
22nd Feb 2011 1:24 pm PRN Issue of Equity
FTSE 100 Latest
Value8,809.74
Change53.53